Shanghai Rongtai Health Technology Corporation Limited (603579.SS) has a MoatMap StockRank of 28/100 based on Quality (52/100), Value (33/100), and Momentum (30/100) factor scores. The current signal is SELL. Shanghai Rongtai Health Technology manufactures massage chairs. This is a highly discretionary consumer product with no structural moat, failing both the Peter Lynch demand signal test and the Buffett moat test.
Shanghai Rongtai Health Technology is a leading designer and manufacturer of high-end massage chairs and smart wellness equipment under the 'ROTAI' brand. The company maintains a strong market position through its advanced robotic massage mechanisms, AI-driven health monitoring features, and a robust global ODM/OEM export business. It is a dominant player in the global massage appliance industry, benefiting from rising health consciousness and aging demographics.
| Price | $2.71 |
| Market Cap | $565M |
| P/E (TTM) | 20.28 |
| P/E (Forward) | 11.64 |
| Price/Book | 1.31 |
| Return on Equity | 7.0% |
| Return on Invested Capital | 7.1% |
| Debt/Equity | 9.53 |
| Gross Margin | 30.2% |
| Operating Margin | 7.6% |
| Revenue Growth | 12.0% |
| Dividend Yield | 2.7% |
| Free Cash Flow | $2M |
Shanghai Rongtai Health Technology Corporation Limited operates in the Leisure industry, part of the Consumer Cyclical sector (China).